| scholarly article | Q13442814 |
| P2093 | author name string | J Fujimoto | |
| S Yamasaki | |||
| T Takeda | |||
| N Kiyokawa | |||
| H Nakao | |||
| P2860 | cites work | Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay | Q37156797 |
| Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide. | Q38334764 | ||
| Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity | Q40158183 | ||
| Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery | Q40186741 | ||
| An evaluation of three in vitro cytotoxicity assays | Q42811543 | ||
| The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 shiga-like toxin | Q48318734 | ||
| Typing of verotoxins by DNA colony hybridization with poly- and oligonucleotide probes, a bead-enzyme-linked immunosorbent assay, and polymerase chain reaction. | Q54596095 | ||
| Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins. | Q54645159 | ||
| Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. | Q54698259 | ||
| Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. | Q54763750 | ||
| Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. | Q54765418 | ||
| Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7 | Q69115052 | ||
| Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli | Q27644365 | ||
| Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution | Q27729840 | ||
| Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3 | Q27748877 | ||
| Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group | Q33367628 | ||
| The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome | Q33375970 | ||
| Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections | Q33429817 | ||
| Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects | Q33491823 | ||
| Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1 | Q33492004 | ||
| The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study | Q33494653 | ||
| The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome | Q33504952 | ||
| Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans | Q33505189 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin | Q36973479 | ||
| Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies | Q36997934 | ||
| Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli | Q37031424 | ||
| Isolation and characterization of monoclonal antibodies to Shiga toxin | Q37110126 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| cytotoxicity | Q246181 | ||
| monoclonal antibody | Q422248 | ||
| P304 | page(s) | 5717-5722 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity | |
| P478 | volume | 67 |
| Q35091607 | Antibody recognition of Shiga toxins (Stxs): computational identification of the epitopes of Stx2 subunit A to the antibodies 11E10 and S2C4 |
| Q35581606 | Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli. |
| Q37672981 | Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model |
| Q33340641 | Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection |
| Q38843829 | Impact of the nature and size of the polymeric backbone on the ability of heterobifunctional ligands to mediate shiga toxin and serum amyloid p component ternary complex formation |
| Q42251450 | In silico analysis of Shiga toxins (Stxs) to identify new potential vaccine targets for Shiga toxin-producing Escherichia coli. |
| Q36329665 | Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities. |
| Q36099489 | Monoclonal antibodies and toxins--a perspective on function and isotype |
| Q39625812 | Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins |
| Q33337841 | Prospects for the prevention of haemolytic-uraemic syndrome |
| Q35220377 | The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide |
| Q27684790 | The Molecular Mechanism of Shiga Toxin Stx2e Neutralization by a Single-domain Antibody Targeting the Cell Receptor-binding Domain |
| Q54337514 | The design of new adjuvants for mucosal immunity to Neisseria meningitidis B in nasally primed neonatal mice for adult immune response. |
Search more.